Volume 3,Issue 2
164.88°三螺旋结构重组Ⅲ 型人源化胶原蛋白：从基础研究到多领域应用
重组人源化胶原蛋白是合成生物学与结构生物学交叉领域的创新成果。2018年，我国科学家首次发现并解析了人Ⅲ型胶原蛋白核心功能区的164.88°柔性弯曲三螺旋结构，为规模制备高生物学活性、低免疫原性的重组人源化胶原蛋白奠定了分子基础。基于这一研究范式，我国已在全球率先实现重组人源化胶原蛋白冻干纤维、溶液、凝胶全品类产品的自主创新与产业化。本文系统梳理了164.88°三螺旋结构的发现历程与分子基础，总结了该材料在化妆品、食品、医疗等领域的研究进展，分析了其安全性特征与产业化现状，并对未来发展方向进行了展望。
[1]Ricard-Blum S. The collagen family[J]. Cold Spring HarborPerspectives in Biology, 2011, 3(1): a004978.
[2]Shoulders M D, Raines R T. Collagen structure and stability[J].Annual Review of Biochemistry, 2009, 78: 929-958.
[3]Varani J, Dame M K, Rittie L, et al. Decreased collagen productionin chronologically aged skin: roles of age-dependent alteration in fibroblastfunction and defective mechanical stimulation[J]. American Journalof Pathology, 2006, 168(6): 1861-1868.
[4]Davison-Kotler E, Marshall W S, García-Gareta E. Sources of collagenfor biomaterials in skin wound healing[J]. Bioengineering, 2019,6(3): 56.
[5]Hua C, Zhu Y, Xu W, et al. Characterization by high-resolution crystalstructure analysis of a triple-helix region of human collagen typeIII with potent cell adhesion activity[J]. Biochemical and BiophysicalResearch Communications, 2019, 508(4): 1018-1023.
[6]Bai M, Kang N, Xu Y, et al . The influence of tag sequence on recombinanthumanized collagen (rhCol) and the evaluation of rhCol onSchwann cell behaviors[J]. Regen Biomater. 2023,10,:rbad089.
[7]王建,范毓慧,李丹凤, 等.重组人源化胶原蛋白基于体外水平的护肤功效研究[J]. 日用化学工业( 中英文), 2024, 54(9): 1030-1038.
[8]陈传秀. 重组Ⅲ型人源化胶原蛋白化妆品的体外抗衰功效研究[J]. CDCST 2024, 1(2):38–42.
[9]Chen C X, Zhang Y Y, Yang J B, et al. An overview of progress inthe application of recombinant collagen in cosmetics[J]. The Journal ofDermatologic Science and Cosmetic Technology, 2024, 1(4): 100059.9[10]Zhang Z, Yang W, Yang J, et al. Evaluation of the safety and functionaleffects of recombinant humanized type III collagen in food toxicology[J]. Front. Med. 13:1765276.
[11]国家药品监督管理局. 重组Ⅲ型人源化胶原蛋白冻干纤维获批上市[EB/OL]. (2021-06-29)[2026-05-28]. https://www.nmpa.gov.cn/zhuanti/cxylqx/cxylqxlm/20210629141635133.html.
[12]Wang Q , An Q , Wang Y ,et al.Development and mechanistic investigationof recombinant type Ⅲ humanized collagen gel for mid-facialsoft tissue repair[J].Collagen and Leather, 2025, 14(2).
[13] 龙存林, 张敏娟, 任戬, 等. 重组胶原蛋白在医疗器械领域的应用进展[J]. 中国医疗器械杂志, 2025, 49(6): 640-646.
[14] 盖潇潇, 孙晓霞, 马文倩, 等. 探究医用重组人源胶原蛋白功能敷料在伤口愈合中的作用[J]. 中国医疗器械杂志, 2025, 49(4): 415-422.
[15]Huang J H, Lei X L, Huang Z W, et al. Bioprinted gelatin-recombinanttype Ⅲ collagen hydrogel promotes wound healing[J]. InternationalJournal of Bioprinting, 2022, 8(2): 517.
[16]Yang L, Wu H S, Lu L, et al. A tailored extracellular matrix (ECM)-mimetic coating for cardiovascular stents by stepwise assembly ofhyaluronic acid and recombinant human type Ⅲ collagen[J]. Biomaterials,2021, 276: 121055.
[17]Li H, You S, Yang X, et al. Injectable recombinant human collagen-derived material with high cell adhesion activity limits adverseremodelling and improves pelvic floor function in pelvic floor dysfunctionrats[J]. Biomaterials Advances, 2022, 134: 112715.
[18]Shuai X, Kang N, Li Y, et al. Recombination humanized type IIIcollagen promotes oral ulcer healing[J]. Oral Diseases, 2024, 30: 1286-1295.
[19]Liu X, Li H, Wang T, et al. Recombinant humanized collagen typeIII with high antitumor activity inhibits breast cancer cells autophagy,proliferation, and migration through DDR1[J]. Int J Biol Macromol,2023,15(243):125-130.
[20]Zeng H, Li H, Wang L, et al. Recombinant humanized type III collageninhibits ovarian cancer and induces protective anti-tumor immunityby regulating autophagy through GSTP1[J]. Mater Today Bio, 2024,28:101220.
[21]Liu W, Hu C, Long L, et al. An injectable carrier for spatiotemporaland sequential release of therapeutic substances to treat myocardial infarction[J]. Journal of Controlled Release : Official Journal of the ControlledRelease Society, 2024,365:29-42.
[22]国家药品监督管理局药品审评中心. 山西锦波生物医药股份有限公司重组Ⅲ型人源化胶原蛋白冻干纤维药用辅料登记[DB/OL].(2025-09)[2026-05-28]. https://www.cde.org.cn.